Cana Laboratories, a subsidiary of Cosmos Health (COSM), has secured a contract manufacturing agreement with Provident Pharmaceuticals to produce 4.32 million units of DE3-SOLE OR.SOL.SDC 25000 IU/2.5ML (BTx4 vials x 2.5 ml).